Breakthrough of the year 2013. Cancer immunotherapy

Science. 2013 Dec 20;342(6165):1432-3. doi: 10.1126/science.342.6165.1432.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use
  • CTLA-4 Antigen / antagonists & inhibitors*
  • CTLA-4 Antigen / immunology
  • Clinical Trials as Topic
  • Humans
  • Immunotherapy / trends*
  • Ipilimumab
  • Melanoma / immunology
  • Melanoma / mortality
  • Melanoma / therapy
  • Neoplasms / immunology*
  • Neoplasms / mortality
  • Neoplasms / therapy*
  • T-Lymphocytes / immunology

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Ipilimumab